334 related articles for article (PubMed ID: 15834444)
21. Working heart function in diabetes is not improved by spironolactone treatment.
Verma S; Yuen VG; Badiwala M; Anderson TJ; McNeill JH
Can J Physiol Pharmacol; 2003 May; 81(5):493-6. PubMed ID: 12774856
[TBL] [Abstract][Full Text] [Related]
22. KR-31762, a novel KATP channel opener, exerts cardioprotective effects by opening SarcKATP channels in rat models of ischemia/reperfusion-induced heart injury.
Lee SH; Yang MK; Lim JH; Seo HW; Yi KY; Yoo SE; Lee BH; Won HS; Lee CS; Choi WS; Shin HS
Arch Pharm Res; 2008 Apr; 31(4):482-9. PubMed ID: 18449506
[TBL] [Abstract][Full Text] [Related]
23. Additive effects of combined valsartan and spironolactone on cardiac aldosterone escape in spontaneously hypertensive rats.
Liang YH; Wang JM; Zhou Y; Jiang XJ; Jiang H; Huang CX
Life Sci; 2004 Aug; 75(15):1871-8. PubMed ID: 15302230
[TBL] [Abstract][Full Text] [Related]
24. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spironolactone and losartan regarding long-term blood pressure and target organ damage.
Baumann M; Hermans JJ; Janssen BJ; Peutz-Kootstra C; Witzke O; Heemann U; Smits JF; Boudier HA
J Hypertens; 2007 Dec; 25(12):2504-11. PubMed ID: 17984673
[TBL] [Abstract][Full Text] [Related]
25. Preconditioning actions of aldosterone through p38 signaling modulation in isolated rat hearts.
Yoshino T; Nagoshi T; Anzawa R; Kashiwagi Y; Ito K; Katoh D; Fujisaki M; Kayama Y; Date T; Hongo K; Yoshimura M
J Endocrinol; 2014 Aug; 222(2):289-99. PubMed ID: 24895416
[TBL] [Abstract][Full Text] [Related]
26. [Effects of aldosterone and spironolactone on the proliferation and collagen synthesis of hepatic stellate cells in rats].
Yao JF; Yao XX; Fang HM; Cui DL; Bai WY
Zhonghua Yi Xue Za Zhi; 2003 Oct; 83(20):1823-5. PubMed ID: 14642092
[TBL] [Abstract][Full Text] [Related]
27. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
Cavallari LH; Fashingbauer LA; Camp JR; King ST; Geenen DL
J Renin Angiotensin Aldosterone Syst; 2008 Sep; 9(3):146-53. PubMed ID: 18957385
[TBL] [Abstract][Full Text] [Related]
28. Different regulation of cardiac and renal corticosteroid receptors in aldosterone-salt treated rats: effect of hypertension and glucocorticoids.
Silvestre JS; Robert V; Escoubet B; Heymes C; Oubénaïssa A; Desopper C; Swynghedauw B; Delcayre C
J Mol Cell Cardiol; 2000 Jul; 32(7):1249-63. PubMed ID: 10860767
[TBL] [Abstract][Full Text] [Related]
29. Aldosterone synthase inhibition improves cardiovascular function and structure in rats with heart failure: a comparison with spironolactone.
Mulder P; Mellin V; Favre J; Vercauteren M; Remy-Jouet I; Monteil C; Richard V; Renet S; Henry JP; Jeng AY; Webb RL; Thuillez C
Eur Heart J; 2008 Sep; 29(17):2171-9. PubMed ID: 18586661
[TBL] [Abstract][Full Text] [Related]
30. Genomic and nongenomic dose-dependent biphasic effect of aldosterone on Na+/H+ exchanger in proximal S3 segment: role of cytosolic calcium.
Leite-Dellova DC; Oliveira-Souza M; Malnic G; Mello-Aires M
Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1342-52. PubMed ID: 18715944
[TBL] [Abstract][Full Text] [Related]
31. Early nongenomic events in aldosterone action in renal collecting duct cells: PKCalpha activation, mineralocorticoid receptor phosphorylation, and cross-talk with the genomic response.
Le Moëllic C; Ouvrard-Pascaud A; Capurro C; Cluzeaud F; Fay M; Jaisser F; Farman N; Blot-Chabaud M
J Am Soc Nephrol; 2004 May; 15(5):1145-60. PubMed ID: 15100355
[TBL] [Abstract][Full Text] [Related]
32. AT1 and aldosterone receptors blockade prevents the chronic effect of nandrolone on the exercise-induced cardioprotection in perfused rat heart subjected to ischemia and reperfusion.
Marques-Neto SR; Ferraz EB; Rodrigues DC; Njaine B; Rondinelli E; Campos de Carvalho AC; Nascimento JH
Cardiovasc Drugs Ther; 2014 Apr; 28(2):125-35. PubMed ID: 24258356
[TBL] [Abstract][Full Text] [Related]
33. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
34. Dietary salt restriction activates mineralocorticoid receptor signaling in volume-overloaded heart failure.
Mori T; Kurumazuka D; Matsumoto C; Shirakawa H; Kimura S; Kitada K; Kobayashi K; Matsuda H; Hayashi T; Kitaura Y; Matsumura Y
Eur J Pharmacol; 2009 Nov; 623(1-3):84-8. PubMed ID: 19766104
[TBL] [Abstract][Full Text] [Related]
35. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
36. Aldosterone induces collagen synthesis via activation of extracellular signal-regulated kinase 1 and 2 in renal proximal tubules.
Xu G; Liu A; Liu X
Nephrology (Carlton); 2008 Dec; 13(8):694-701. PubMed ID: 19154323
[TBL] [Abstract][Full Text] [Related]
37. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
38. Mineralocorticoid receptor antagonist spironolactone prevents pig serum-induced hepatic fibrosis in rats.
Fujisawa G; Muto S; Okada K; Kusano E; Ishibashi S
Transl Res; 2006 Sep; 148(3):149-56. PubMed ID: 16938653
[TBL] [Abstract][Full Text] [Related]
39. [Brain mineralocorticoid receptor and blood pressure control in the conscious normotensive rat].
Rahmouni K; Barthelmebs M; Imbs JL; De Jong W
Arch Mal Coeur Vaiss; 1998 Aug; 91(8):1009-12. PubMed ID: 9749155
[TBL] [Abstract][Full Text] [Related]
40. Spironolactone prevents alterations associated with cardiac hypertrophy produced by isoproterenol in rats: involvement of serum- and glucocorticoid-regulated kinase type 1.
Martín-Fernández B; de las Heras N; Miana M; Ballesteros S; Valero-Muñoz M; Vassallo D; Davel AP; Rossoni LV; Cachofeiro V; Lahera V
Exp Physiol; 2012 Jun; 97(6):710-8. PubMed ID: 22327331
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
